SKB BIO Sets 17 Aug 2026 Board Meeting to Approve 1H26 Interim Results; Announces Same-Day Webcast

Bulletin Express

08/05

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has scheduled a board meeting for Monday, 17 August 2026. Directors will consider and approve the company’s interim results for the six months ended 30 June 2026 and authorize their release.

Following the results announcement, management will host a webcast conference call at 8:00 p.m. Hong Kong/Beijing time (12:00 noon GMT; 8:00 a.m. U.S. Eastern). Participants can access the event through the investor-relations section of the company’s website or directly via https://kelun-biotech-2026-interim-results-conf-aug.open-exchange.net/. Registration at least 30 minutes in advance is recommended.

Board composition remains unchanged, comprising Chairman and Non-executive Director Liu Gexin, Executive Director Ge Junyou, six other Non-executive Directors, and four Independent Non-executive Directors.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1188136923"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1188136923\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1188136923?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-05 16:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1188136923","market":"hk","top_or_hot":-1,"title":"SKB BIO Sets 17 Aug 2026 Board Meeting to Approve 1H26 Interim Results; Announces Same-Day Webcast","media":"Bulletin Express","content":"<p>Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has scheduled a board meeting for Monday, 17 August 2026. Directors will consider and approve the company’s interim results for the six months ended 30 June 2026 and authorize their release.</p>\n<p>Following the results announcement, management will host a webcast conference call at 8:00 p.m. Hong Kong/Beijing time (12:00 noon GMT; 8:00 a.m. U.S. Eastern). Participants can access the event through the investor-relations section of the company’s website or directly via https://kelun-biotech-2026-interim-results-conf-aug.open-exchange.net/. Registration at least 30 minutes in advance is recommended.</p>\n<p>Board composition remains unchanged, comprising Chairman and Non-executive Director Liu Gexin, Executive Director Ge Junyou, six other Non-executive Directors, and four Independent Non-executive Directors.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SKB BIO Sets 17 Aug 2026 Board Meeting to Approve 1H26 Interim Results; Announces Same-Day Webcast</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSKB BIO Sets 17 Aug 2026 Board Meeting to Approve 1H26 Interim Results; Announces Same-Day Webcast\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-05 16:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has scheduled a board meeting for Monday, 17 August 2026. Directors will consider and approve the company’s interim results for the six months ended 30 June 2026 and authorize their release.</p>\n<p>Following the results announcement, management will host a webcast conference call at 8:00 p.m. Hong Kong/Beijing time (12:00 noon GMT; 8:00 a.m. U.S. Eastern). Participants can access the event through the investor-relations section of the company’s website or directly via https://kelun-biotech-2026-interim-results-conf-aug.open-exchange.net/. Registration at least 30 minutes in advance is recommended.</p>\n<p>Board composition remains unchanged, comprising Chairman and Non-executive Director Liu Gexin, Executive Director Ge Junyou, six other Non-executive Directors, and four Independent Non-executive Directors.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06990","symbol_name":"科伦博泰生物","start_time":0,"source_url":"","article_id":"1188136923","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1188136923","pubTimestamp":1785919828,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has scheduled a board meeting for Monday, 17 August 2026. Directors will consider and approve the company’s interim results for the six...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06990":"科伦博泰生物"},"translate_title":"SKB BIO 定于 2026 年 8 月 17 日召开董事会会议，批准 26 年上半年中期业绩；宣布当天网络广播","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06990":1},"content_text":"Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (SKB BIO) has scheduled a board meeting for Monday, 17 August 2026. Directors will consider and approve the company’s interim results for the six months ended 30 June 2026 and authorize their release.\nFollowing the results announcement, management will host a webcast conference call at 8:00 p.m. Hong Kong/Beijing time (12:00 noon GMT; 8:00 a.m. U.S. Eastern). Participants can access the event through the investor-relations section of the company’s website or directly via https://kelun-biotech-2026-interim-results-conf-aug.open-exchange.net/. Registration at least 30 minutes in advance is recommended.\nBoard composition remains unchanged, comprising Chairman and Non-executive Director Liu Gexin, Executive Director Ge Junyou, six other Non-executive Directors, and four Independent Non-executive Directors.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}